Sleep-disordered breathing (SDB) is recognized as a serious health problem that impacts approximately 43 million US adults. More than 80% remain undiagnosed, and many barriers prevent patients from getting access to therapy.
Now, the detection of this chronically debilitating condition has been made easier with the ApneaLink Plus, a Type III home sleep testing diagnostic device, the latest addition to the ApneaLink family of diagnostic products and accessories.
The ApneaLink devices provide you with a costeffective, easy-to-use method of diagnosing or screening patients for obstructive sleep apnea (OSA) in the home. The device reports apneas, hypopneas, fl ow limitation, snoring, blood oxygen saturation and the probability of Cheyne-Stokes respiration (CSR) breathing patterns within the recording.